Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Schmidt, V. Liebenberg, T. DeVos, J. Distler, R. Tetzner, A. Seegebarth, S. Weickmann, C. Witt, M. Fleischhacker (Berlin, Berlin/Seattle, Germany). PTGER4, a promising novel DNA methylation marker for lung cancer measured in a clinical case control study using blood plasma. Eur Respir J 2008; 32: Suppl. 52, 3534

Member's Comments

No comment yet.

Related content which might interest you: SHOX2 DNA methylation is a promising biomarker for the diagnosis of lung cancer in plasma Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 RARβ2 methylation level in blood for lung cancer assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Cancer-associated oncogenic BARD1 isoforms: From biomarker expression studies to development of a blood test for early detection of lung cancer Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 The detection of quantitative serum p53 protein in lung cancer and its clinical value Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003 Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003 DNA methylation and lung function: an epigenome-wide association study Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Can high levels of serum tumor markers be useful in predicting the histologic type of lung cancer? Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 The correlation between p53 gene mutation and the expression of tumor drug resistance genes in lung cancer and its clinical significance Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004 DNA methylation marker for NSCLC and adjacent normal lung tissue using NotI-MseI methylation chip Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007 DR-70, A promising biomarker for the detection of lung cancer> Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Role of complement activation product C4d as apredictor biomarker in lung cancer diagnosis : case control study Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Development of a new sensitive ELISA for the determination in serum of uteroglobin-related protein 1 (UGRP-1), a new potential lung biomarker Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010 Abnormal expression of let-7a miRNA in blood of lung cancer patient Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 DNA methylation markers of surfactant proteins in lung cancer Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 The clinical significance of plasma DNA quantification in NSCLC Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011